Mo Liu

4.5k total citations · 1 hit paper
86 papers, 2.3k citations indexed

About

Mo Liu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mo Liu has authored 86 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 16 papers in Cancer Research and 15 papers in Oncology. Recurrent topics in Mo Liu's work include Advanced Database Systems and Queries (12 papers), Data Management and Algorithms (11 papers) and MicroRNA in disease regulation (8 papers). Mo Liu is often cited by papers focused on Advanced Database Systems and Queries (12 papers), Data Management and Algorithms (11 papers) and MicroRNA in disease regulation (8 papers). Mo Liu collaborates with scholars based in China, United States and Taiwan. Mo Liu's co-authors include Mien‐Chie Hung, Chun‐Te Chen, Weiya Xia, Chia‐Wei Li, Wen-Hsuan Yu, Chi-Hong Chao, Yan Xiong, Heng‐Huan Lee, Sumaiyah K. Rehman and Dihua Yu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Mo Liu

80 papers receiving 2.3k citations

Hit Papers

p53 regulates epithelial–mesenchymal transition and stem ... 2011 2026 2016 2021 2011 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mo Liu China 21 1.5k 701 520 179 176 86 2.3k
Heng Li China 25 1.2k 0.8× 936 1.3× 185 0.4× 70 0.4× 87 0.5× 91 2.0k
Limei Hu United States 33 2.2k 1.5× 1.3k 1.9× 663 1.3× 120 0.7× 219 1.2× 88 3.5k
Yingqi Xu China 22 955 0.7× 454 0.6× 189 0.4× 582 3.3× 222 1.3× 78 2.2k
Feng Xiao China 25 1.3k 0.9× 309 0.4× 178 0.3× 53 0.3× 221 1.3× 103 2.0k
Yuting Liu China 29 1.7k 1.2× 629 0.9× 698 1.3× 61 0.3× 435 2.5× 83 3.0k
Sidharth Kumar United States 9 987 0.7× 461 0.7× 304 0.6× 114 0.6× 147 0.8× 35 1.5k
Chunlei Zheng China 28 897 0.6× 376 0.5× 407 0.8× 89 0.5× 214 1.2× 96 2.1k
Zongyuan Yang China 21 673 0.5× 356 0.5× 276 0.5× 38 0.2× 108 0.6× 70 1.4k
Xinli Huang China 26 724 0.5× 458 0.7× 135 0.3× 129 0.7× 156 0.9× 101 1.7k
Amit Arora India 23 1.8k 1.2× 318 0.5× 403 0.8× 40 0.2× 80 0.5× 79 2.6k

Countries citing papers authored by Mo Liu

Since Specialization
Citations

This map shows the geographic impact of Mo Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Liu more than expected).

Fields of papers citing papers by Mo Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mo Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Liu. The network helps show where Mo Liu may publish in the future.

Co-authorship network of co-authors of Mo Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Mo Liu. A scholar is included among the top collaborators of Mo Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mo Liu. Mo Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xinyi, et al.. (2025). An Expanding Universe of Mutational Signatures and Its Rapid Evolution in Single-Stranded RNA Viruses. Molecular Biology and Evolution. 42(2).
2.
Liu, Mo, et al.. (2023). mSigHdp: hierarchical Dirichlet process mixture modeling for mutational signature discovery. NAR Genomics and Bioinformatics. 5(1). lqad005–lqad005. 4 indexed citations
3.
Boot, Arnoud, Mo Liu, Willie Yu, et al.. (2022). Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers. Proceedings of the National Academy of Sciences. 119(4). 27 indexed citations
5.
Rajan, Kaushik Sunder, et al.. (2020). Generalized Sub-Query Fusion for Eliminating Redundant I/O from Big-Data Queries.. Operating Systems Design and Implementation. 209–224. 1 indexed citations
6.
Tian, Tian, Xiaobin Lv, Guokai Pan, et al.. (2019). Long Noncoding RNA MPRL Promotes Mitochondrial Fission and Cisplatin Chemosensitivity via Disruption of Pre-miRNA Processing. Clinical Cancer Research. 25(12). 3673–3688. 60 indexed citations
7.
Tu, Jian, Zijun Huo, Mo Liu, et al.. (2018). Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickase. Stem Cell Research. 28. 29–32. 10 indexed citations
8.
Zhou, Ruoji, An Xu, Donghui Wang, et al.. (2018). A homozygous p53 R282W mutant human embryonic stem cell line generated using TALEN-mediated precise gene editing. Stem Cell Research. 27. 131–135. 7 indexed citations
9.
Liu, Mo, Linchao Lu, Ruoji Zhou, et al.. (2018). Generation of an induced pluripotent stem cell line from an individual with a heterozygous RECQL4 mutation. Stem Cell Research. 33. 36–40. 2 indexed citations
10.
Xu, An, Ruoji Zhou, Jian Tu, et al.. (2018). Establishment of a human embryonic stem cell line with homozygous TP53 R248W mutant by TALEN mediated gene editing. Stem Cell Research. 29. 215–219. 7 indexed citations
11.
Zhang, Chiyuan, et al.. (2018). Role of Noncoding RNA in Pulmonary Arterial Hypertension and Potential Drug Therapeutic Target. Current Topics in Medicinal Chemistry. 18(12). 975–986. 7 indexed citations
12.
Zhou, Ruoji, An Xu, Jian Tu, et al.. (2018). Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells. Journal of Visualized Experiments. 9 indexed citations
13.
Huo, Zijun, Jian Tu, An Xu, et al.. (2018). Generation of a heterozygous p53 R249S mutant human embryonic stem cell line by TALEN-mediated genome editing. Stem Cell Research. 34. 101360–101360. 7 indexed citations
14.
Xia, Fei, Yanjun Wang, Lirong Liang, et al.. (2017). The relationship between benign paroxysmal positional vertigo and cerebrovascular disease in the elderly. Zhonghua laonian yixue zazhi. 36(10). 1087–1091. 1 indexed citations
15.
Huang, Wukui, et al.. (2017). S-1 for treatment of advanced hepatocellular carcinoma: a systematic review of the literature. Współczesna Onkologia. 1(1). 16–20. 3 indexed citations
17.
Huang, Wukui, et al.. (2015). Jinlong capsule decreases adverse reactions after transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinoma ⁎. Oncology and Translational Medicine. 1(2). 87–91. 3 indexed citations
18.
Xue, Yuwen, Jian Chen, Liem Phan, et al.. (2012). HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53. Cell Cycle. 11(22). 4181–4190. 28 indexed citations
19.
Zhang, Bin, et al.. (2011). The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma. Journal of Oral Pathology and Medicine. 41(2). 141–148. 27 indexed citations
20.
Hsu, Jung-Mao, Chun‐Te Chen, Chao‐Kai Chou, et al.. (2011). Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation. Nature Cell Biology. 13(2). 174–181. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026